Physician profile
Nathaniel W Johns
NPI 1942265947
$2,106.22
in general payments reported to CMS, 2019-2025
12 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $53.20 · 2021: $222 · 2022: $488 · 2023: $174 · 2024: $499 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $626.59 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $500.70 | 2021-2025 | Azstarys |
| Sunovion Pharmaceuticals INC. | $366.66 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $263.28 | 2019-2024 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $160.61 | 2025 | Jornay Pm |
| Tris Pharma INC | $53.73 | 2022-2024 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $34.08 | 2020 | |
| Tempus Ai, INC | $29.43 | 2024 | |
| Abbvie INC. | $23.16 | 2022 | |
| Neos Therapeutics, LP | $19.84 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.23 | 2024 | Relexxii |
| Shire North American Group INC | $13.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Johns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.